Stocks · Health care · Services-Medical Laboratories

BIODESIX INC

BDSX Clue Score48
United States Fiscal year ends December CIK 0001439725 Results filed 5 Nov 2026

What the insiders did No buying or selling

By person

11 insiders · 0 transactions
1.8×

Scott Hutton holds only 1.8 times base salary in stock. $1.19M of shares against $643.40K in salary for 2025.

Salary from the company's own proxy. The shares are what Scott Hutton last reported holding, valued at $24.47, the price Common Stock was last bought or sold at on the open market here, on 12 Aug 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Lawrence T. Kennedy Jr
Director
—
—
—
10,411,024
$254.72M
+0.5%
Jack W Schuler
10% owner
—
—
—
555,810
$13.60M
—
Charles M Watts
Director
—
—
—
421,705
$10.32M
+12.4%
John Patience
Director
—
—
—
378,536
$9.26M
+25.1%
Hany Massarany
Director
—
—
—
310,135
$7.59M
+9.3%
Jean M. Franchi
Director
—
—
—
108,140
$2.65M
+32.2%
Scott Hutton
President & CEO
—
—
—
48,767
$1.19M
—
Robin Harper Cowie
CFO, Sec'y & Treasurer
—
—
—
16,231
$397.11K
—
Gary Anthony Pestano
Chief Development Officer
—
—
—
10,359
$253.44K
—
Kieran O'Kane
Chief Commercial Officer
—
—
—
9,819
$240.23K
—
Chris Vazquez
Chief Accounting Officer
—
—
—
1,586
$38.80K
—

No percentages here. This company's share count has moved by a factor of 18.4 over the window, from 7,955,685 to 146,633,352 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.